Wall Street loves growth stories. Venture capitalists love disruption stories. But one of the oldest and most reliable ways fortunes are made in the stock market is much simpler.

Companies buy other companies.

Every market cycle brings a wave of consolidation. Sometimes it happens quietly in small niches. Sometimes it explodes into megadeals that dominate headlines for months. Either way, when industries start consolidating, it creates some of the best opportunities in the market for patient investors.

Over the last six months, we have started to see the early stages of another consolidation wave across several major U.S. industries. The activity is not random. It is concentrated in specific sectors where scale matters, costs are rising, and strategic positioning is becoming more important than ever.

Here are the 8 stocks to buy on this consolidation wave.

The sectors leading this trend right now include consumer health and personal care, semiconductors, medical devices and healthcare technology, and media and entertainment. Each of these industries has seen major announced transactions, and the rationale behind those deals tells us a lot about where the next opportunities may appear.

Just as important, the valuation math behind these deals gives us a real-time look at what strategic buyers are willing to pay.

And that is where things get interesting.

The Current Consolidation Landscape

Across the six months ending March 7, 2026, U.S. merger activity remained surprisingly active despite volatile markets and macro uncertainty. Monthly deal counts stayed consistently high, often running between roughly one thousand and thirteen hundred announced transactions in a given month.

More importantly, the largest deals repeatedly appeared in the same handful of industries. When the biggest buyers consistently target the same sectors, it usually signals structural change inside those industries.

In other words, consolidation is not just happening. It is accelerating.

The most visible consolidation stories during this period include:

• Consumer health and household personal care companies combining brand portfolios and distribution systems.
• Semiconductor suppliers merging to achieve scale in research, manufacturing, and global sales.
• Medical device companies acquiring high-growth technology platforms.
• Media companies combining content libraries and streaming infrastructure to survive the economics of the modern entertainment market.

Each of these industries has a different strategic logic driving deals, but they all share one common theme.

Scale matters more than ever.

See Where Breakouts Begin Before The Market Reacts

FDA decisions, earnings surprises, and corporate deals can move stocks fast. Benzinga Pro delivers exclusive headlines directly from its newsroom before the broader market reacts. This is how traders stay positioned when momentum starts. Start Free Trial

Why Industries Consolidate

Consolidation rarely happens because executives suddenly feel generous. It usually happens because competitive pressures force companies to become larger, more efficient, or more technologically capable.

In consumer products, consolidation often revolves around distribution power. When companies combine brands, they gain stronger negotiating leverage with retailers and can cut significant costs from overlapping supply chains and marketing budgets.

Semiconductors consolidate for a different reason. The cost of developing advanced chips keeps rising. Companies need larger revenue bases to support massive research and development spending.

Medical technology deals are driven by innovation. Larger companies frequently acquire smaller platforms that already have promising products rather than spending years developing them internally.

Media consolidation is largely about survival. The shift to streaming has created enormous content costs and technology investments that many standalone companies cannot support alone.

When you look at the deals announced over the past six months, the strategic motivations behind them become very clear.

The Multiples Tell the Story

One of the most interesting findings from recent M&A activity is how dramatically valuation multiples differ by industry.

In consumer health and personal care, deal valuations are typically anchored around EBITDA multiples in the mid-teens. These deals are often justified by large synergy targets and operational efficiencies that reduce the effective purchase price over time.

Semiconductor mergers appear more expensive if you look strictly at earnings multiples, but those numbers are misleading. Many semiconductor companies report depressed GAAP earnings due to restructuring cycles or heavy research spending. Buyers focus instead on long-term scale and adjusted profitability.

Medical device transactions command the highest multiples of all. Some recent deals imply extremely high EV-to-EBITDA ratios because buyers are paying for growth and technological differentiation rather than mature cash flow.

Media deals, on the other hand, are often valued using synergy-adjusted forward EBITDA rather than current earnings. Streaming investments and content amortization make traditional earnings metrics far less useful in this sector.

The bottom line is that strategic buyers are not all using the same valuation framework. Each industry has its own deal math.

Understanding that math helps us identify where the next acquisitions may occur.

Consumer Health and Personal Care

One of the clearest consolidation stories today is in consumer health and household personal care products.

These companies operate massive brand portfolios that compete for shelf space in the same retail channels. Combining companies can immediately eliminate duplicate costs in logistics, manufacturing, marketing, and distribution.

A recent headline deal in the sector involved the combination of Kimberly-Clark (NASDAQ:KMB) and Kenvue (NYSE:KVUE). The transaction was framed around complementary product categories and a massive synergy target estimated at roughly $2.1 billion in annual cost savings. The valuation was cited at roughly 14.3 times last-twelve-month adjusted EBITDA, with the effective multiple falling once synergy savings are included.

Deals like this create ripple effects across the entire industry. Competitors begin asking the same question.

Should we buy someone else before someone buys us?

That is why investors should keep an eye on companies like Perrigo (NYSE:PRGO) and Edgewell Personal Care (NYSE:EPC).

Perrigo operates in the self-care consumer health segment, producing over-the-counter medicines and wellness products sold through retailers around the world. The company recently disclosed that its infant formula division is undergoing a strategic review, a phrase that often precedes asset sales or broader corporate restructuring. Perrigo's balance sheet also carries meaningful leverage, which can make a strategic buyer or private equity sponsor an appealing solution for unlocking value.

Edgewell Personal Care, known for brands across shaving products and personal care categories, has already begun reshaping its portfolio. The company recently agreed to sell its Feminine Care business to Essity for approximately $340 million. The divestiture highlights management's willingness to streamline operations and focus on core product categories. With leverage around four times EBITDA and margins under pressure from tariffs and promotional spending, Edgewell represents exactly the kind of mid-sized consumer brand platform that frequently becomes an acquisition candidate during industry consolidation.

Semiconductor Consolidation

Semiconductors have always been cyclical, but the economics of the industry increasingly favor larger players.

The cost of designing advanced chips, maintaining fabrication partnerships, and supporting global sales networks has grown dramatically. As a result, companies in niche semiconductor categories often seek mergers that expand their scale and customer reach.

A major recent example was the combination of Skyworks Solutions (NASDAQ:SWKS) and Qorvo (NASDAQ:QRVO), two key suppliers of radio-frequency components used in smartphones and wireless infrastructure. The transaction highlighted the scale benefits of combining engineering teams, manufacturing capacity, and global distribution networks.

Beyond the headline mergers, several smaller semiconductor companies could eventually become acquisition targets.

MaxLinear (NASDAQ:MXL) is one such candidate. The company develops radio-frequency, analog, and mixed-signal integrated circuits used in broadband, wireless, and connectivity applications. After a difficult period tied to a terminated merger agreement with Silicon Motion, MaxLinear has returned to growth and non-GAAP profitability. Its modest debt levels and specialized technology platform make it a logical acquisition candidate for a larger semiconductor firm seeking to expand its connectivity portfolio.

Power Integrations (NASDAQ:POWI) is another interesting possibility. The company designs high-voltage power conversion semiconductors used in everything from data centers to electric vehicles and power grids. Management has pointed to long-term demand drivers including artificial intelligence infrastructure and electrification. The company recently announced a workforce reduction aimed at improving efficiency, and its balance sheet carries substantial liquidity with minimal debt. That combination of strong technology and financial flexibility often attracts strategic buyers looking for differentiated platforms.

Medical Device and Healthcare Technology

Medical technology is one of the most consistent consolidation stories in corporate America.

Large medical device companies routinely acquire innovative smaller firms rather than building new technologies internally. These acquisitions allow them to expand product portfolios and leverage existing global sales networks.

A recent example involved Boston Scientific (NYSE:BSX) agreeing to acquire Penumbra (NYSE:PEN), reflecting the industry's willingness to pay premium multiples for differentiated medical technology platforms.

Two companies stand out as potential candidates in this space.

Integer Holdings (NYSE:ITGR) operates as a contract manufacturer for the medical device industry, producing components and systems used in cardiovascular, neuromodulation, and other medical technologies. The company generates substantial revenue and adjusted EBITDA while maintaining leverage levels that remain manageable for private equity sponsors. Recent reports of activist pressure pushing the company to explore strategic alternatives have added fuel to speculation that Integer could eventually be sold to a larger medical device company or private equity group.

Avantor (NYSE:AVTR) represents a different type of opportunity. The company supplies tools, materials, and services used by life sciences and biotechnology companies. With more than $6 billion in annual sales and over $1 billion in adjusted EBITDA, Avantor operates a large platform that could be attractive to strategic buyers seeking scale in life sciences supply chains. Management has launched an internal turnaround program aimed at improving margins and operational efficiency. Companies undertaking large internal transformations often attract acquisition interest from buyers who believe they can accelerate those improvements.

Media and Entertainment

Few industries have changed more dramatically in the past decade than media.

Streaming platforms have transformed the economics of television and film. Traditional networks are losing subscribers while technology investments continue to rise.

That dynamic is forcing consolidation.

A major recent transaction involved Paramount Skydance Corporation combining with Warner Bros. Discovery (NASDAQ:WBD). The deal was structured around massive expected synergies exceeding $6 billion and valued the combined company at roughly 7.5 times forward EBITDA after integration benefits.

Smaller media companies may find themselves drawn into similar consolidation stories.

AMC Networks (NASDAQ:AMCX) is a prime example. The company has been transitioning its business toward streaming while maintaining profitable cable networks. Despite generating meaningful free cash flow, its market capitalization remains relatively small. With over $1.7 billion in long-term debt and declining traditional television revenue, AMC Networks could eventually become a takeover candidate for a larger media or technology company looking to expand content libraries and streaming capabilities.

Roku (NASDAQ:ROKU) sits on the opposite end of the spectrum. The company has built one of the most widely used streaming platforms in the world, generating billions in revenue and hundreds of millions in adjusted EBITDA. Roku also maintains a strong balance sheet with significant cash reserves. While its valuation is far higher than many traditional media companies, the strategic importance of its platform could attract interest from larger technology or advertising companies seeking deeper integration into the streaming ecosystem.

What This Means for Investors

Consolidation waves rarely happen all at once.

They usually start with a few large deals that set the tone for an industry. Competitors watch closely, boards begin strategic reviews, and investment bankers quietly circulate pitch books outlining potential combinations.

Eventually the pace accelerates.

The last six months suggest that we are entering the early stages of that process in several industries.

Consumer health companies are combining brand portfolios to gain distribution power.

Semiconductor firms are merging to fund the rising cost of innovation.

Medical technology companies are acquiring growth platforms to expand product pipelines.

Media companies are consolidating content and streaming infrastructure to survive a new economic reality.

For investors, these shifts create opportunities.

Acquisition premiums can appear suddenly and dramatically. Companies that once traded quietly for years can become takeover targets almost overnight.

Identifying the industries where consolidation is already underway is the first step.

Finding the companies most likely to be acquired is the second.

And right now, those opportunities are quietly forming across several corners of the market.

The big deals are already happening.

The next ones may not be far behind.